available for iOS, Android and web
Bags immediate sales under the deal
Buys meningitis C and tick borne encephalitis jabs
But sales slip as generics continue to bite
TC-5214 reaches end of the line after failing to impress in mid-stage trial
DH needs to re-engage with patients
Top drugs still performing well
US OKs use for diabetic macular oedema
Now cleared for treating VTE and preventing its recurrence
A waste of time or way forward?
.